Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
Recruiting · NCT06254469 · Registry updated 2025-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease | Alzheimer disease, Brain Damage, Chronic, Brain Injuries, Traumatic, Chronic Disease, Craniocerebral Trauma, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain injury, central nervous system disorder, cognitive disorder, dementia, dementia pugilistica, injury, nervous system disorder, nervous system injury, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 3 | 2025-07-30 | NCT06254469 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CereMark Pharma, LLC | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Endeavor Health Systems | Evanston | United States | 1 |